Check out StreetInsider for much more detail on Canaccord's stellar forecast for AMRN
It seems Ritu is assuming Self-marketing in her price target of 26 or 27$/share as the current scenario.
I agree -Buyouts will delay the launch. At some point Joe Z. has to make a decision on LAUNCH. I think by midlle of Nov.-Decision will be announced--probably by end of Oct.2012.
Question. Newbie here. Does anybody really care when a launch occurs? I mean, if there is a buyout the PPS would automatically go to that price and most would be happy with profit taking. The only ones who would care about whether a launch was delayed are the ones who are holding very long. Yes?
Yes-- There will be more news about different pharmacy groups agreeing to sell Vascepa-thus pushing Stock price up regularly as is happening with VVUS today after their announcement last month that their drug's availability date.